Buradasınız

Anasayfa » Content

HEMODİYALİZ HASTALARINDA HİPERTANSİYON SIKLIĞI VE VOLÜM KONTROLÜNÜN ÖNEMİ

PREVALANCE OF HYPENTENSION IN HEMODIALYSIS PATIENTS AND THE IMPORTANCE OF VOLUME CONTROL

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Hypertension (HT) is very common in hemodialysis (HD) patients, and this is the most important factor that increase cardiovascular morbidity and mortality. In this study, we determimined theprevalance ofHT ( 2140/90 mmHg) and the effect of one year strict volume control on blood pressure levels in 57 patients (28 females, 29 'males) undergoing HD in our HD unit since April 1999. Although almost half of the patients (49.1%) were taking antihypertensive drugs, 33 percent of them were still hypertensive on April 1999. These patients had a greater interdialytic weight gain (4.5%). In addition to strict salt restriction, persistent ultrafiltration was applied until achieving dialysis hypotension. Antihypertensive drugs of the patients whose blood pressure reduced with volume control were discontinued gradually. With this procedure, systolic and diastolic blood pressure levels significantly reduced (from 134.5+24.9 mmHg to 125.8+18.0 mmHg, p=0.005 and form 79.3+15.9 mmHg to 76.1+11.7 mmHg, p=0.067, respectively) and the prevalence of HT was decreased to 5.3% at the end of one year period. We concluded that normal blood pressure levels could be reached in most of the patients with strict volume control by ultrafiltration. Therefore, before starting antihypertensive drug treatment the real dry weight should be achieved by strict volume control in HD patients.
Bookmark/Search this post with
Abstract (Original Language): 
Hemodiyaliz, (HD) hastalarında hipertansiyona (HT) sık rastlanmakta olup, bu hastalarda HTkardiovasküler morbidite ve mortaliteyi artıran en önemli faktördür. Biz bu çalışmada, HD ünitemizde Nisan 1999da, hemodiyalize girmekte olan toplam 57 (28 K, 29 E) hastada hipertansiyon ( >140/90 mmHg ) sıklığını ve bir yıl süreli sıkı volüm kontrolü uygulamasının kan basıncı düzeylerine etkisini araştırdık. Nisan 1999da hastaların yaklaşık yarısı (% 49.1 'i) antihipertansif ilaç kullanmasına rağmen, üçte biri (%33) halen hipertansifti. Bu hastalarda aşırı interdiyalitik kilo artışı (%4.5) olduğu gözlendi. Hastalara sıkı tuz kısıtlamasına ilaveten diyaliz hipotansiyonu oluşana dek tedrici ultrafiltrasyon uygulamasına geçildi. Volüm kontrolü ile kan basıncı düşen hastaların antihipertansif ilaçları tedrici olarak kesildi. Bu uygulama ile bir yılın sonunda; sistolik ve diastolik kan basınçlarında önemli azalma [sırasıyla 134.5+24.9 mmHgdan 125.8+18.0 mmHg'ya (p=0.005) ve 79.3+15.9 mmHgdan 76.1 ±11.7 mmHg'ya (p= 0.067)] gözlendi ve hipertansiyon sıklığının % 5.3'e düştüğü tespit edildi. Sonuç olarak, sıkı ultrafiltrasyon uygulaması ile volüm kontrolü sağlanan hastaların çoğunda kan basıncının kontrol altına alındığı tespit edildi. Bu nedenle HD hastalarında, antihipertansif ilaç başlamadan evvel sıkı volüm kontrolü ile gerçek kuru ağırlığa ulaşılması öncelikli hedef olmalıdır.
FULL TEXT (PDF): 
PDF icon pdf_tndt_372.pdf
  • 1
32-35
  • Turkish

REFERENCES

References: 

1. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J, Vanel T: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
2.
Silberber
g JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end¬: stage renal disease. Kidney Int 1989;36:286-290.
3. Tozawa M, Iseki K, Fukiyama K: Hypertension in dialysis patients: A cross-sectional analysis. Jpn J Nephrol 1997;3:129-135.
4. Salem MM: Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis
26:461-468, 1995.
5. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel
KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992; 19:453¬459.
6. Blumberg A, Nelp WD, Hegstrom RM, Scribner BH: Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction.
Lancet 1967;2:69-73.
7. Özkahya M, Töz H, Unsal A ve ark.: Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor. Am J Kidney Dis 1999;34(2):218-221.
8. Joint National Committee on Detection. Evaluation and Treatment of High Blood Pressure. The Sixt report of the joint National committee on Prevention, Detection and Treatment of High Blood Pressure (JNCVI). Arch
Intern Med 1997;157:2413-2446.
9. Herrera-Acosta J: Hypertension in chronic renal disease.
Kidney Int 1982;22:702-712.
10. Kirchner KA: Hypertension in hemodialysis patients: More questions than answers. Am J Kidney Dis 1997;30:577-578.
11. Coomer RW, Schulman G, Breyer J A, Shyr Y: Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytic blood pressure. Am J Kidney Dis 1997;29:678-684.
12. Dionisio P, Valenti M, Bergia R et al: Influence of hydration state on blood pressure values in a group of
patientss on regular maintenance hemodialysis. Blood Purif 1997;1:25-33.
13. Rahman M, Dixit A, Donley V et al.: factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 1999;33 (3):498-506.
35

Thank you for copying data from http://www.arastirmax.com